Precision medicine is transforming cancer care. Oncolytic's AI platform takes it further - profiling over a dozen cancer types from blood tests, then recommending targeted therapies with 90%+ accuracy.Backed by oncology and machine learning experts, we developed proprietary algorithms matching complex biomarkers to emerging treatments. Clinicians now access this analysis instantly, selecting options minimizing side effects.Validated by leading centers, Oncolytic integrates heterogenous patient data. Partnerships also power discovery, from biomarkers to drug combinations. Our growing global network accelerates progress against cancer.
